Tag : Molecular Imaging

Latest News

Purdue-developed 'fluorescent markers' begin Phase 3 clinical trials

Newsemia
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has...
Latest News

Study suggests potential therapy option for early-stage breast cancer

Newsemia
Radionuclide therapy has proven successful in delaying the growth of disseminated tumor cells (DTCs) in early-stage breast cancer in a small animal model, suggesting its...
Latest News

Finding non-invasive nuclear medicine technique to predict effectiveness of therapy for tumors

Newsemia
Researchers have taken a critical step toward developing a non-invasive nuclear medicine technique that can predict the effectiveness of therapy for cancerous tumors, allowing for...
Latest News

Researchers discover early biomarker for degenerative neurologic disease

Newsemia
Researchers have discovered a novel radioligand that can effectively differentiate progressive supranuclear palsy (PSP) from similar brain disorders, allowing for earlier and more reliable diagnosis...
Latest News

First safe, reliable, noninvasive way to monitor rheumatoid arthritis

Newsemia
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive...
Latest News

Case studies explain the potential benefits of total-body PET/CT imaging

Newsemia
Case studies from the first total-body positron emission tomography/computed tomography (PET/CT) scanner reveal multiple benefits of the novel imaging technology, providing a solid groundwork upon...
Latest News

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Newsemia
Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of disease beyond the prostate. Source link...
Latest News

Major pitfall identified in popular prostate cancer PET imaging method

Newsemia
Prostate-specific membrane antigen positron emission tomography imaging has become a popular method for determining the stage of a patient’s prostate cancer. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy